Weitere Kapitel dieses Buchs durch Wischen aufrufen
The emergence of the biopharmaceutical companies has led to transformation in the procedures of drug discovery within the firms and emergence of the whole organization within the industry. Patents are the most important form of intellectual property protection for these companies. The patent cliff from 2015 to 2020 is significant as it signals an opportunity for growth. Since 2005, with the new patent regime in India the competition in the domestic market has increased. This chapter aims to understand the patent landscape for biopharmaceutical companies by conducting a firm-level study. The overall industry analysis is not within the scope. The period for study was chosen from 2005 to 2015, and it provided a snapshot of the patent situation of these companies. The methodology adopted for the study required framing the research questions, defining objectives, identifying search strategy from the free patent databases and analysing the results of the search. An open source tool called “The Lens” was used for analysis. A variety of patent indicators (like date, jurisdictions, classification, document type, publications and infringements) were used to draw patent statistics. This was analysed based on number of factors like—publications by year, coverage by jurisdictions, relationship among technologies, economic and technical utility and patents being an indicator of innovation.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Aurobindo Pharma. (2016). Annual Report 2016. Hyderabad: Aurobindo Pharma.
Aurobindo Pharma Ltd. (2015). Driving sustainable growth—Annual Report 2014–15. Hyderabad: Aurobindo Pharma Ltd.
Biocon. (2016). Biocon about us page. Retrieved November 28, 2016, from http://www.biocon.com/biocon_aboutus.asp.
Biocon. (2016). History. Retrieved November 27, 2016, from http://www.biocon.com/biocon_aboutus_history.asp.
Biocon Ltd. (2015). Exclusively inclusive—Annual Report 2015. Bangalore: Biocon Ltd.
Biocon Ltd. (2016). Credibly capable—Annual Report 2016. Bangalore: Biocon Limited. Retrieved from http://www.biocon.com/docs/Biocon_AR_2016_Consolidated_AR.pdf.
Building Foundations of IP. (2016). Retrieved from http://www.wipo.int/ipadvantage/en/details.jsp?id=2602.
Calo-Fernandez, B., & Martínez-Hurtado, J. L. (2012). Biosimilars: Company strategies to capture value from the Pharmaceuticals. Retrieved from www.mdpi.com/journal/pharmaceuticals.
Dechezleprêtre, A., Ménière, Y., & Mohnen, M. (2017, March). International patent families: From application strategies to statistical indicators. LSE Research Online: March 2017. Retrieved from http://eprints.lse.ac.uk/69486/7/Dechezlepretre_International%20patent%20families%20published_2017.pdf.
Dhir, S. (2016). Practice-oriented insights on creative problem solving. Journal of Management & Public Policy, 7(2).
Dhir, S., & Dhir, S. (2017). Adoption of open-source software versus proprietary software: An exploratory study. Strategic Change, 26(4), 363–371. CrossRef
Dhir, S., & Dhir, S. (2015). Diversification: Literature review and issues. Strategic Change, 24(6), 569–588. CrossRef
Dhir, S., & Mital, A. (2013). Value creation on bilateral cross-border joint ventures: Evidence from India. Strategic Change, 22(5–6), 307–326. CrossRef
Dr. Reddy’s. (2015). Annual Report 2014–15. Hyderabad: Dr. Reddy’s.
Dr. Reddy’s. (2016). Annual Report 2015–2016. Hyderabad: Dr. Reddy’s.
Economic Times. (2016). Time for India to be innovator nation in bio-pharmaceuticals: Expert, PTI. New Delhi: Press Trust of India. Retrieved from http://economictimes.indiatimes.com/small-biz/startups/time-for-india-to-be-innovator-nation-in-bio-pharmaceuticals-expert/articleshow/52532569.cms.
Ellen Krabbe, S. S. (2017). Patent searching using free search tools. Intellectual Property Owner’s Association.
Grayson, M. (2015). PhRMA. Retrieved May 6, 2017, from http://catalyst.phrma.org/5-reasons-why-biopharmaceutical-patents-are-different.
Hall, B. H., Jaffe, A., & Trajtenberg, M. (2005, January 01). Market value and patent citations. Rand Journal of Economics. Retrieved from http://eml.berkeley.edu/~bhhall/papers/HallJaffeTrajtenberg03.pdf.
Hall, B. H., Thoma, G., & Torrisi, S. (2007, September). The market value of patents and R&D: Evidence from European firms. Cambridge, MA: National Bureau of Economic Research.
Kalegaonkar, A., Locke, R., & Lehrich, J. (2008, November 4). Biocon India Group. MIT Solan Management Review, 08–081. Retrieved from https://mitsloan.mit.edu/LearningEdge/CaseDocs/08-081%20Biocon%20India%20Group%20Case.pdf.
Khan, S. A., & Nasim, S. (2016). Impact of product patent regime on pharmaceutical companies in India. In C. J. Sushil (Ed.), Flexible work organizations: The challenges of capacity building in Asia, flexible systems management. New Delhi: Springer.
Leydesdorff, L. (2008). Patent classifications as indicators of intellectual organization. Journal of the Association for Information Science & Technology, 59(10). Retrieved from http://www.leydesdorff.net/wipo06/wipo06.pdf. CrossRef
Löfgren, H. (2007). The global biopharma industry and the rise of Indian drug multinationals: Implications for Australian generics policy. Australian and New Zealand Health Policy, v.4(PMC1896171), PMC1896171. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896171/. CrossRef
Lupin Ltd. (2015). Annual Report 2014–2015. Lupin Ltd.
PwC. (2016). 2016 Patent litigation study are we at an. USA: PwC. Retrieved from https://www.pwc.com/us/en/forensic-services/publications/assets/2016-pwc-patent-litigation-study.pdf.
Rathod, S. K. (2016). Injunctions in Indian pharmaceutical patent injunctions in Indian pharmaceutical patent. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2758327.
Squicciarini, M., Dernis, H., & Criscuolo, C. (2013, June). Measuring patent quality—Indicators of technological and economic value. In OECD science, technology and industry working papers (p. 69). Retrieved from http://www.oecd-ilibrary.org/science-and-technology/measuring-patent-quality_5k4522wkw1r8-en.
Srinivasamani, V. (2015). Process patent litigation in pharma sector—An overview. Lakshmikumaran & Sridharan. Retrieved from http://www.lakshmisri.com/News-and-Publications/Publications/Articles/IPR/process-patent-litigation-in-pharma-sector-an-overview.
Sterzi, L. O. (2010). Comparative study of the use of patents in different industries. Milano: KITeS -Bocconi University.
Sun Pharmaceuticals. (2015). Annual Report 2014–2015. Sun Pharmaceutical.
The Measurement of Scientific and Technological Activities using Patent Data as Science and Technology Indicators. (1994). Paris: Organisation for Economic Co-Operation and Development. Retrieved from https://www.oecd.org/sti/inno/2095942.pdf.
WHO. (2016). Insulin patent profile. WHO, Retrieved from http://apps.who.int/medicinedocs/documents/s22481en/s22481en.pdf.
Wikipedia. (2017). Dr. Reddy’s Laboratories.
WIPO. (2008). World patent report: A statistical review—2008 edition. WIPO. Retrieved from http://www.wipo.int/ipstats/en/statistics/patents/wipo_pub_931.html.
WIPO. (2015). Guidelines for preparing patent landscape reports. Retrieved May 2017, from http://www.wipo.int/edocs/pubdocs/en/wipo_pub_946.pdf.
WIPO. (2016). Patent databases: The lens. Retrieved from https://poldham.github.io/lens/.
WIPO. (n.d.). Innovating India’s pharmaceutical industry. Retrieved May 10, 2017, from http://www.wipo.int/ipadvantage/en/details.jsp?id=2659.
Zacharias, N., & Farias, S. (2002). Patents and the Indian pharmaceutical industry. Mumbai: Business Briefing: Pharmatech.
- Patent Landscape for Indian Biopharmaceutical Sector: A Strategic Insight
- Springer Singapore
- Chapter 3
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, digitale Transformation/© Maksym Yemelyanov | Fotolia